Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gad Getz

Showing results (141-150 of 397) with videos related to

Pageof 40
Sort By:
Nature Genetics|June 30, 2018
Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variationEric R Gamazon, Ayellet V Segrè, Martijn van de Bunt, et al.
Nature Genetics|January 22, 2013
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsPriscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, et al.
Nature|December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumoursAmaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Nature Cancer|December 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatmentCatherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, et al.
Cancer Discovery|June 11, 2021
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease HistoryLivius Penter, Satyen H Gohil, Caleb Lareau, et al.
Nature Biotechnology|June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor typesYuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
Nature|April 14, 2022
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumoursRebecca C Larson, Michael C Kann, Stefanie R Bailey, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitorsRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell CarcinomaKent W Mouw, James M Cleary, Brendan Reardon, et al.
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Pageof 40

Showing results (141-150 of 397) with videos related to

Sort By:
Pageof 40
Nature Genetics|June 30, 2018
Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variationEric R Gamazon, Ayellet V Segrè, Martijn van de Bunt, et al.
Nature Genetics|January 22, 2013
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsPriscilla K Brastianos, Peleg M Horowitz, Sandro Santagata, et al.
Nature|December 2, 2016
Genomic evolution and chemoresistance in germ-cell tumoursAmaro Taylor-Weiner, Travis Zack, Elizabeth O'Donnell, et al.
Nature Cancer|December 23, 2021
Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatmentCatherine Gutierrez, Aziz M Al'Khafaji, Eric Brenner, et al.
Cancer Discovery|June 11, 2021
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease HistoryLivius Penter, Satyen H Gohil, Caleb Lareau, et al.
Nature Biotechnology|June 23, 2014
Assessing the clinical utility of cancer genomic and proteomic data across tumor typesYuan Yuan, Eliezer M Van Allen, Larsson Omberg, et al.
Nature|April 14, 2022
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumoursRebecca C Larson, Michael C Kann, Stefanie R Bailey, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitorsRomanos Sklavenitis-Pistofidis, Elizabeth D Lightbody, Mairead Reidy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell CarcinomaKent W Mouw, James M Cleary, Brendan Reardon, et al.
Cancer Cell|January 18, 2014
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapyJens G Lohr, Petar Stojanov, Scott L Carter, et al.
Pageof 40